Publication | Closed Access
Osimertinib is associated with reversible and dose-independent cancer therapy-related cardiac dysfunction
35
Citations
31
References
2020
Year
CardiomyopathyHeart FailureMedicinePharmacologyCardiovascular PharmacologyPharmacotherapyCancer TreatmentCardiovascular ToxicityOncologyCardiologyCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1